GSK's (GSK) "Buy" Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft restated their buy rating on shares of GSK (LON:GSK - Free Report) in a research note released on Wednesday morning, MarketBeat.com reports. Deutsche Bank Aktiengesellschaft currently has a GBX 1,950 ($24.27) price target on the stock.

Several other analysts also recently weighed in on the stock. Barclays reiterated an equal weight rating and issued a GBX 1,725 ($21.47) price objective on shares of GSK in a research report on Monday, April 8th. Berenberg Bank lifted their price objective on shares of GSK from GBX 1,650 ($20.54) to GBX 1,820 ($22.66) and gave the company a buy rating in a research report on Wednesday, February 14th. Finally, Shore Capital reissued a buy rating on shares of GSK in a research note on Thursday, March 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, GSK has an average rating of Hold and a consensus price target of GBX 1,630.63 ($20.30).

GSK Stock Performance

LON:GSK traded down GBX 20.50 ($0.26) during mid-day trading on Wednesday, hitting GBX 1,590 ($19.79). The stock had a trading volume of 6,002,987 shares, compared to its average volume of 7,157,902. The stock has a market capitalization of £65.03 billion, a price-to-earnings ratio of 1,325.00, a P/E/G ratio of 1.09 and a beta of 0.27. The company has a 50 day simple moving average of GBX 1,665.40 and a 200-day simple moving average of GBX 1,544.74. GSK has a 52 week low of GBX 1,302.60 ($16.22) and a 52 week high of GBX 1,719.80 ($21.41). The company has a current ratio of 0.88, a quick ratio of 0.73 and a debt-to-equity ratio of 140.82.

GSK Increases Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, April 11th. Stockholders of record on Thursday, February 22nd were paid a GBX 16 ($0.20) dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a dividend yield of 1.04%. This is a boost from GSK's previous dividend of $14.00. GSK's payout ratio is currently 5,333.33%.

Insider Transactions at GSK

In other news, insider Emma Walmsley sold 139,792 shares of GSK stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.64), for a total value of £2,317,751.36 ($2,885,287.39). In other news, insider Emma Walmsley sold 139,792 shares of GSK stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of GBX 1,658 ($20.64), for a total value of £2,317,751.36 ($2,885,287.39). Also, insider Julie Brown bought 19,360 shares of the company's stock in a transaction dated Thursday, February 1st. The stock was purchased at an average cost of GBX 1,583 ($19.71) per share, for a total transaction of £306,468.80 ($381,512.26). Insiders have acquired 19,802 shares of company stock valued at $31,381,484 in the last quarter. Insiders own 1.71% of the company's stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.